Femasys (FEMY) announces the receipt of the Medicines & Healthcare products Regulatory Agency approvals for the FemaSeed Intratubal Insemination product for female infertility treatment and two diagnostic devices, FemVue for tubal evaluation and FemCerv for cervical cancer detection.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY: